NCT02879422View on ClinicalTrials.gov

Genetic Markers and Proliferative Diabetic Retinopathy

NACompletedINTERVENTIONAL
Enrollment

302

Participants

Timeline

Start Date

October 16, 2013

Primary Completion Date

March 3, 2020

Study Completion Date

January 31, 2021

Conditions
Proliferative Diabetic Retinopathy
Interventions
GENETIC

genetic analysis

Trial Locations (1)

51092

Chu de Reims, Reims

All Listed Sponsors
lead

CHU de Reims

OTHER

NCT02879422 - Genetic Markers and Proliferative Diabetic Retinopathy | Biotech Hunter | Biotech Hunter